Meyer-Rienecker H J, Jenssen H L, Werner H
J Neurol Sci. 1979 Jul;42(2):173-86. doi: 10.1016/0022-510x(79)90049-2.
Some new results of cell-mediated immunity in multiple slcerosis (MS) are presented, based on the determination of charge-changing lymphokines as products of antigen sensitive lymphocytes (C PAL), obtained by several forms of the electrophoretic mobility (EM) method. Lymphocytes from MS react to myelin basic protein (BP), the reactivity in other neurological diseases depending on the degree of destruction of nervous parenchyma. Applying a membrane-associated antigen from normal brain (NTA), positive reactivity of MS lymphocytes was obtained. Besides the usual determination of lymphokines in vitro the sensitive EM test allows the demonstration of lymphokine activities in vivo; i.e. in body fluids such as cerebrospinal fluid (CSF) and serum. In CSF of MS a high lymphokine activity was found. The differentiation of lymphokines and comparison between in vitro and in vivo activity were carried out. Moreover, a characteristic lymphokine pattern for MS with high activities in all regions of molecular weight, especially in the CSF, could be detected. On the basis of these findings, important also from the pathogenetic point of view, a diagnostic scheme for MS is suggested, consisting of a program of determination of the immuno-reactive CSF syndrome and some special procedures, including examination of lymphocyte reactivity.
本文基于采用多种形式的电泳迁移率(EM)方法测定作为抗原敏感淋巴细胞产物的电荷变化淋巴因子(C PAL),介绍了多发性硬化症(MS)细胞介导免疫的一些新结果。MS患者的淋巴细胞对髓鞘碱性蛋白(BP)有反应,其他神经疾病中的反应性则取决于神经实质的破坏程度。应用来自正常大脑的膜相关抗原(NTA),获得了MS淋巴细胞的阳性反应。除了常规的体外淋巴因子测定外,灵敏的EM试验还能证明体内淋巴因子的活性,即在脑脊液(CSF)和血清等体液中的活性。在MS患者的脑脊液中发现了高淋巴因子活性。对淋巴因子进行了区分,并比较了体外和体内活性。此外,还能检测到MS的特征性淋巴因子模式,在所有分子量区域,尤其是脑脊液中,活性都很高。基于这些从发病机制角度来看也很重要的发现,提出了一种MS诊断方案,包括免疫反应性脑脊液综合征的测定程序和一些特殊程序,包括淋巴细胞反应性检查。